CAPTRUST Financial Advisors
KLDO

CAPTRUST Financial Advisors’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

CAPTRUST Financial Advisors’s Portfolio KLDO Stock Details KLDO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-129
Closed – – 4628
2022
Q2 		$0 Sell
129
-515
-80% -$466 ﹤0.01% 5320
2022
Q1 		$1K Hold
644
– – ﹤0.01% 4832
2021
Q4 		$2K Hold
644
– – ﹤0.01% 4490
2021
Q3 		$4K Buy
644
+46
+8% +$285 ﹤0.01% 4079
2021
Q2 		$4K Buy
+598
New +$4.24K ﹤0.01% 3983

CAPTRUST Financial Advisors's KLDO Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q3 2022, closing a stake of 129 shares.

CAPTRUST Financial Advisors first reported a position in KLDO in Q2 2021 and held it in 5 quarters. The position peaked at $4K in Q3 2021. 0 funds tracked by Wall St. Rank hold KLDO as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 129 Kaleido Biosciences, Inc. Common Stock shares in Q3 2022.
  • CAPTRUST Financial Advisors first reported a position in Kaleido Biosciences, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
  • CAPTRUST Financial Advisors's Kaleido Biosciences, Inc. Common Stock position peaked at $4K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.